Shares of Landec LNDC fell 2.4% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 112.50% over the past year to $0.02, which beat the estimate of $0.01.
Revenue of $130,904,000 declined by 8.20% from the same period last year, which missed the estimate of $134,240,000.
Guidance
Landec Sees FY21 Sales $530M-$550M vs $546M Estimate, Adj. EBITDA $33M-$37M
How To Listen To The Conference Call
Date: Jan 06, 2021
Time: 05:00 PM
ET Webcast URL: http://public.viavid.com/player/index.php?id=142705
Technicals
52-week high: $11.89
52-week low: $7.48
Price action over last quarter: Up 11.58%
Company Profile
Landec Corp designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets, and license technology applications to partners. It has two proprietary polymer technology platforms, Intelimer polymers, and hyaluronan biopolymers. The company also sells specialty packaged branded Eat Smart and GreenLine and private label fresh-cut vegetables and whole produce to retailers, club stores, and foodservice operators. Its segments are Curation Foods segment, the Lifecore segment, and the Other. It derives key revenue from the Packaged fresh vegetable segment which includes the marketing and packing of specialty packaged whole and fresh-cut fruit and vegetables. The company has the business presence in the US and other countries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.